Transcription of Public Assessment Report - GOV.UK
{{id}} {{{paragraph}}}
PAR Flucloxacillin 250 mg & 500 mg Capsules PL 21880/0017-0018; UK/H/1101/01-02/DC 1 Public Assessment Report Decentralised Procedure Flucloxacillin 250 mg Capsules Flucloxacillin 500 mg Capsules (flucloxacillin) Procedure No: UK/H/1101/0 01-002/DC UK Licence No: PL 21880/0 017-0018 Medreich plc PAR Flucloxacillin 250 mg & 500 mg Capsules PL 21880/0017-0018; UK/H/1101/01-02/DC 2 LAY SUMMARY Flucloxacillin 250mg Capsules Flucloxacillin 500mg Capsules (flucloxacillin) This is a summary of the Public Assessment Report (PAR) for Flucloxacillin 250 mg and 500 mg Capsules (PL 21880/0017-0018; UK/H/1101/001-002/DC).
This is a summary of the Public Assessment Report (PAR) for Flucloxacillin 250 mg and 500 mg Capsules (PL 21880/0017-0018; UK/H/1101/001-002/DC).
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}